145 related articles for article (PubMed ID: 7723200)
1. Suppression of graft rejection in rat keratoepithelioplasty by anterior chamber inoculation of donor lymphocytes.
Yao YF; Inoue Y; Hara Y; Kiritoshi A; Tano Y; Ohashi Y
Jpn J Ophthalmol; 1994; 38(4):345-52. PubMed ID: 7723200
[TBL] [Abstract][Full Text] [Related]
2. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):292-300. PubMed ID: 9040461
[TBL] [Abstract][Full Text] [Related]
3. T-cell-mediated immune responses in alloepithelial rejection after murine keratoepithelioplasty.
Miyazaki D; Inoue Y; Yao YF; Okada AA; Shimomura Y; Hayashi K; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2590-7. PubMed ID: 10509654
[TBL] [Abstract][Full Text] [Related]
4. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
5. Role of tumor necrosis factor receptor expression in anterior chamber-associated immune deviation (ACAID) and corneal allograft survival.
Niederkorn JY; Mayhew E; Mellon J; Hegde S
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2674-81. PubMed ID: 15277491
[TBL] [Abstract][Full Text] [Related]
6. Anterior chamber-associated immune deviation promotes corneal allograft survival.
Niederkorn JY; Mellon J
Invest Ophthalmol Vis Sci; 1996 Dec; 37(13):2700-7. PubMed ID: 8977485
[TBL] [Abstract][Full Text] [Related]
7. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
Yamada J; Kurimoto I; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
[TBL] [Abstract][Full Text] [Related]
8. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
Ishioka M; Okamoto S; Streilein JW; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
[TBL] [Abstract][Full Text] [Related]
9. Ocular resurfacing and alloepithelial rejection in a murine keratoepithelioplasty model.
Yao YF; Inoue Y; Miyazaki D; Shimomura Y; Ohashi Y; Tano Y
Invest Ophthalmol Vis Sci; 1995 Dec; 36(13):2623-33. PubMed ID: 7499085
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and antigenicity of allogeneic amniotic epithelial transplants grafted to the cornea, conjunctiva, and anterior chamber.
Wang M; Yoshida A; Kawashima H; Ishizaki M; Takahashi H; Hori J
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1522-32. PubMed ID: 16565388
[TBL] [Abstract][Full Text] [Related]
11. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
[TBL] [Abstract][Full Text] [Related]
12. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
[TBL] [Abstract][Full Text] [Related]
13. The antigen-bearing eye and the spleen are indispensable in maintaining anterior chamber-associated immune deviation.
Yao YF; Inoue Y; Miyazaki D; Hara Y; Shimomura Y; Tano Y; Ohashi Y
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):534-9. PubMed ID: 9040487
[TBL] [Abstract][Full Text] [Related]
14. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
15. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection.
Koevary SB; Beaudry K
Ocul Immunol Inflamm; 2000 Mar; 8(1):39-47. PubMed ID: 10806433
[TBL] [Abstract][Full Text] [Related]
16. Intracameral injection of allogeneic lymphocytes enhances corneal graft survival.
She SC; Steahly LP; Moticka EJ
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1950-6. PubMed ID: 2210990
[TBL] [Abstract][Full Text] [Related]
17. Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.
Minamoto A; Sakata H; Okada K; Fujihara M
Jpn J Ophthalmol; 1995; 39(1):12-9. PubMed ID: 7543958
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
19. [Implantation of FK506 drug delivery system into the anterior chamber for inhibiting corneal rejection in high risk rabbit corneal allograft].
Shi WY; Liu T; Xie LX; Wang SG
Zhonghua Yan Ke Za Zhi; 2006 Apr; 42(4):299-304. PubMed ID: 16762204
[TBL] [Abstract][Full Text] [Related]
20. Xenoreactive CD4+ T cells and acute rejection of orthotopic guinea pig corneas in mice.
Tanaka K; Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1827-32. PubMed ID: 10845605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
